Showing results (181-190 of 331) with videos related to

Sort By:
Pageof 34
AIDS (London, England)|August 17, 2005
Anal intraepithelial neoplasia in the highly active antiretroviral therapy era among HIV-positive men who have sex with menJoel M Palefsky, Elizabeth A Holly, Jimmy T Efirdc, et al.
International Journal of Cancer|August 13, 2013
Progression of anal high-grade squamous intraepithelial lesions to invasive anal cancer among HIV-infected men who have sex with menJ Michael Berry, Naomi Jay, Ross D Cranston, et al.
JAMA|May 14, 1997
Clinically recognized dysplastic nevi. A central risk factor for cutaneous melanomaM A Tucker, A Halpern, E A Holly, et al.
Prostate Cancer and Prostatic Diseases|January 17, 2007
Highly elevated PSA and dietary PhIP intake in a prospective clinic-based study among African AmericansK T Bogen, G A Keating, J M Chan, et al.
Blood|June 17, 2004
Polymorphisms and haplotypes in folate-metabolizing genes and risk of non-Hodgkin lymphomaChristine F Skibola, Matthew S Forrest, Fabio Coppedé, et al.
Melanoma Research|February 6, 2002
Rarity of CDK4 germline mutations in familial melanomaA M Goldstein, A Chidambaram, A Halpern, et al.
Neuroepidemiology|January 1, 1997
A study of pediatric brain tumors and their association with epilepsy and anticonvulsant useJ G Gurney, B A Mueller, S Preston-Martin, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 1, 1995
Recognition and classification of clinically dysplastic nevi from photographs: a study of interobserver variationP Hartge, E A Holly, A Halpern, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 26, 2004
Body mass index, leptin and leptin receptor polymorphisms, and non-hodgkin lymphomaChristine F Skibola, Elizabeth A Holly, Matthew S Forrest, et al.
Cancer Causes & Control : CCC|October 25, 2003
No increased risk of non-Hodgkin's lymphoma with steroids, estrogens and psychotropics (Netherlands)Annette B Beiderbeck, Elizabeth A Holly, Miriam C J M Sturkenboom, et al.
Pageof 34